ISCAYAHL International Symposium for Childhood, Adolescent, and Young Adult Hodgkin Lymphoma

Thursday, October 19, 2023, 8:00 AM - Saturday, October 21, 2023, 5:00 PM, Renasant Convention Center, Memphis, TN

The 5th ISCAYAHL will focus on discussion of the main questions in the field of pediatric, adolescent and young adult (AYA) Hodgkin lymphoma (HL) such as survivorship outcomes, clinical trial portfolios from around the world, novel therapeutics biomarkers and biology and novel imaging of pediatric HL. The goal of this conference is to provide a platform to share work from global collaborations and form new ones.

The International Symposium for Childhood, Adolescent and Young Adult Hodgkin Lymphoma (ISCAYAHL) was first assembled by Dr. Monika Metzger, USA and Dr. Mauz-Körholz, Germany as a chance to engage the global pediatric HL scientific community. The first meeting was held in Arlington, Virginia, in 2011. During this meeting new collaborations and research opportunities arose. Leaders from various pediatric collaborative groups including Children’s Oncology group (COG), European Network for Pediatric HL (EuroNet-PHL), the Pediatric Hodgkin Consortium (PHC) and Asociación de Hemato-Oncología Pediátrica de Centro América (AHOPCA) recognized a profound need to not only standardize response criteria, but also staging criteria to facilitate the interpretation and comparison of clinical studies worldwide. Out of this formed the ongoing Staging Evaluation and Response Criteria Harmonization (SEARCH) initiative.

Mission

To improve survival and quality of life for all children, adolescents and young adults with Hodgkin lymphoma worldwide through collaboration.

For more information, please visit the conference website. 

1. Develop standards of care for children, adolescents, and young adults (AYA) with Hodgkin lymphoma (HL) globally
2. Review clinical science and trial advances for pediatric and AYA HL to harmonize future iterations of trial development
3. Advance use of patient-reported outcomes in HL to improve personalized approaches to care
4. Utilize current state of survivorship research to inform therapeutic advances in HL

Regular registration is now open through the meeting.

• In-person only (at present time)
• Cost: $399 and $249 for LMIC and Trainees/YIs
• Yoga: Sign up for Saturday when registering
• Ask about: daycare, breastfeeding/mother’s room, religious needs, other accommodations

St. Jude Children's Research Hospital is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 

St. Jude Children’s Research Hospital designates this Live Activity for a maximum of 19.75 AMA PRA Category 1 Credits^TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

AMA PRA Category 1 Credits™ (19.75 hours), Non-Physician Attendance (19.75 hours)

Please visit the conference website for hotel information. 

The faculty for this activity are listed below. Click to view the faculty member's financial disclosure information and bio. 

Mitigation of Relevant Financial Relationships

St Jude Children's Research Hospital adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others, are required to disclose all financial relationships with ineligible entities (ie, companies whose primary business is producing, marketing, selling, re-selling, or distributing health care products used by or on patients). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.